Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
Titel:
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
Auteur:
Poveda, A. Vergote, I. Tjulandin, S. Kong, B. Roy, M. Chan, S. Filipczyk-Cisarz, E. Hagberg, H. Kaye, S.B. Colombo, N. Lebedinsky, C. Parekh, T. Gómez, J. Park, Y.C. Alfaro, V. Monk, B.J.